Edwards Lifesciences has received CE mark approval for its Cardioband Tricuspid Valve Reconstruction System, making it the first commercially available transcatheter therapy to treat tricuspid valve heart disease.

The family of a newlywed nurse is suing American Airlines after she fell ill on a flight and died. The cause of her death was determined to be an acute massive pulmonary embolism and cardiogenic shock.

A small study presented at SCAI 2018 demonstrated the potential of 3D printing to help clinicians select the appropriate size for transcatheter heart valves and avoid paravalvular leak (PVL).

Recent research found strain parameters taken from a cine MRI-based deformable registration algorithm (DRA) can determine the severity of amyloid buildup in the heart and may provide prognostic information on patients with light-chain (AL) amyloidosis.

Maltodextrin imaging agents can distinguish bacterial infections from inflamed areas, according to a rat study published in JACC: Cardiovascular Imaging. Ideally, this finding could lead to novel tracers to catch infections from implanted cardiac devices (ICDs) before they require removal.

MRI of cerebral functional network connectivity in comatose patients who recently suffered cardiac arrest may help determine if they will recover cognitive abilities at one year, according to a new study published April 23 in Radiology.

HeartFlow, a California-based medical tech company focused on cardiovascular disease, announced its analysis system has been selected by NHS England as part of its Innovation and Technology Payment (ITP) program.

A new technique for conducting cardiac MRI can be completed within 90 seconds, allows patients to breathe during testing and could ultimately improve diagnostic accuracy and reliability.